Subacute sclerosing panencephalitis (SSPE) is a persistent infection of the central nervous system by the measles virus. Patients in the initial stages of SSPE show behavioral symptoms and usually normal cranial MR imaging findings. We aimed to investigate the gray matter volume changes in patients with early SSPE.
S
ubacute sclerosing panencephalitis (SSPE) is a slow virus infection of the central nervous system, which is caused by the measles virus.
1 It is a rare infectious disease in developed countries. An incidence of 1 case per million patients with measles infection a year was reported in developed countries. 1 However, it is still prevalent in underdeveloped and developing countries. 2 The characteristic clinical presentation of SSPE usually starts with nonspecific cognitive decline and behavioral changes, such as memory impairments, decreased scholastic performance, reduction of social interactions, and emotional instability. 1 Following the behavioral changes, involuntary movements, such as myoclonic jerks and choreoathetosis, develop. Myoclonic jerks initially affect the head and then involve the trunk and limbs with progression of disease. Spasticity, visual disturbances, and language difficulties usually accompany the involuntary movements. In late stages of the disease, mental deterioration evolves, spasticity progresses into opisthotonus, and terminal patients pass into a vegetative state.
T2-weighted hyperintense signal-intensity changes in the cerebral cortex, periventricular white matter, basal ganglia, and brain stem and atrophic dilation of cerebral sulci are the cranial MR imaging findings of SSPE that frequently develop in the late stages of the disease. [3] [4] [5] [6] [7] Conventional cranial imaging performed in the initial stages of SSPE usually does not reveal any pathology. However, recent MR spectroscopy studies have demonstrated that the metabolic alterations caused by neuronal loss and gliosis were present even in normalappearing cerebral tissue in the initial stages of SSPE. 8, 9 Voxelbased morphometry is an automated statistical image-analysis method that is used to search gray matter volume differences between various subject groups. 10 Voxel-based morphometry can detect minor morphologic changes that could not be detected by visual case analyses.
The purpose of the current study was to investigate the gray matter volume changes in the initial stages of SSPE. We studied patients with a diagnosis of SSPE whose conventional cranial MR imaging findings appeared normal. We hypothesized that neuronal degeneration/loss starting in the early stages of SSPE would cause cerebral gray matter loss that could be detected by using voxel-based morphometry. We performed a cross-sectional voxel-based morphometry study to search the gray matter volume differences between the patients with SSPE and age-and sex-matched control subjects. We also studied the correlations between the gray matter distribution and the clinical variables.
Materials and Methods

Patients
We studied 22 patients with a diagnosis of SSPE. Because cerebral parenchymal lesions would cause segmentation errors during image analysis, we excluded 5 patients whose conventional cranial MR images revealed cortical or white matter lesions. Thus, 17 patients (11 girls and 6 boys) were included into the study. The mean age of the patients was 9.5 Ϯ 2.2 years (range, 7-14 years). Table 1 summarizes the demographic data and the clinical findings of these patients. The diagnosis of SSPE was based on the presence of clinical symptoms, typical electroencephalography findings (bilateral periodic high-amplitude slow wave bursts), and high antimeasles antibody titers in serum (Ͼ1:180) and CSF (Ͼ1:4). 1, 11 The mean age of initial measles infection was 28 months (ranging between 8 and 45 months). We used the clinical staging of patients as defined by Jabbour et al. 11 Briefly, stage 1 indicated behavioral changes; stage 2, the presence of myoclonus, incoordination, choreoathetosis, and motor convulsions; stage 3, opisthotonus, decerebrate rigidity, and coma; and stage 4, diminished rigidity, less frequent myoclonus, and loss of cerebral cortical function. Clinical parameters were also quantified by using a neurologic disability index (NDI) as defined previously for patients with SSPE by Dyken et al, 12 in which motor, sensory, and mental states were evaluated; higher scores indicated poorer neurologic status. Neurologic examinations, clinical staging, and NDI scoring were performed by an experienced pediatric neurologist (B.T.). All patients were treated with oral isoprinosine (dosage, 100 mg/kg/day). The patients were compared with a control group composed of 30 healthy subjects (20 girls and 10 boys). The mean age of the control subjects was 9.3 Ϯ 2.4 years (range, 7-14 years). None of the control subjects had a history of any neurologic or psychiatric disorder. The exclusion criteria for the patient and control groups also included any contraindication for MR imaging, a history of previous head trauma leading to hospitalization, and a previous history of febrile or nonfebrile convulsion. Written informed consent was obtained from the parents of the patients and control subjects. The study was approved by the local human subject committee.
Image Acquisition
Cranial MR imaging studies were performed on a 1.5T superconducting whole-body MR imaging system (Symphony Maestro; Siemens Medical Systems, Erlangen, Germany) with a standard quadrature head coil. Conventional cranial MR imaging was performed to search for any pathologic finding that would lead to the exclusion of patients from the study. MR images were evaluated by an experienced neuroradiologist who was blinded to whether images were from a patient or control subject. The conventional cranial MR imaging protocol included axial fluid-attenuated inversion recovery (FLAIR) (TR ϭ 9800 ms, TE ϭ 110 ms, TIϭ 2100 ms, NEX ϭ 2), axial T1-weighted spinecho (TR ϭ 500 ms, TE ϭ 18 ms, NEX ϭ 3), and coronal T2-weighted fast spin-echo (TR ϭ 9200 ms, TE ϭ 110 ms, NEX ϭ 3) sequences. For voxel-based morphometry, high-resolution anatomic images of the whole brain were acquired from the patients and control subjects with T1-weighted magnetization-prepared rapid acquisition gradient echo sequences (TR ϭ 11.08 ms, TE ϭ 4 ms, TI ϭ 300 ms, relaxation delay time ϭ 500 ms, flip angle ϭ 15°, FOV ϭ 256 ϫ 192 mm, matrix size ϭ 256 ϫ 192), yielding 128 sagittal sections with a defined voxel size of 1 ϫ 1 ϫ 1.3 mm.
Voxel-Based Morphometry Protocol and Data Preprocessing
We applied an optimized method of voxel-based morphometry by using SPM2 (http://www.fil.ion.ucl.ac.uk/spm/software/spm2; Wellcome Department of Cognitive Neurology, London, UK) running under Matlab (MathWorks, Natick, Mass). 10, 13 Preprocessing of the data involved spatial normalization of all images into a standardized anatomic space, segmentation into gray and white matter, modulation, and spatial smoothing with a Gaussian kernel. T1-weighted MR images were normalized to the standard T1 template of the Montreal Neurologic Institute (MNI). The normalized images were smoothed and averaged to obtain a study-specific T1 template. All of the original structural MR images in native space were then normalized to this study-specific template. The normalized images were segmented into CSF, gray matter, and white matter compartments by using the SPM2 priors. Afterward, CSF, gray matter, and white matter images were smoothened with an 8-mm full width at half maximum (FWHM) kernel and averaged to obtain study-specific CSF, gray matter, and white matter priors for later segmentation of native images. The original T1-weighted images were segmented with the study-specific T1 template and gray matter, white matter, and CSF priors. This segmentation step involves an affine transformation of each scan to the template with a subsequent back-projection into native space. We also performed a correction for volume changes (modulation) by modu- lating each voxel by the Jacobian determinants derived from the spatial normalization. An automated brain-extraction procedure that incorporated a segmentation step was used to remove nonbrain tissue. The extracted gray and white matter images were then normalized to the specific gray and white matter templates. The normalization parameters were then applied to the original structural images in native space to reduce any contribution from nonbrain voxels and to afford optimal spatial normalization of gray matter. These normalized images were segmented into gray and white matter. Finally, the normalized and segmented images were smoothed with an 8-mm FWHM isotropic Gaussian kernel.
Statistical Analysis
The normalized modulated smoothed gray matter data were analyzed by using SPM2, within the framework of the general linear model on a voxel-wise comparison. Regional differences in gray matter volume between the patients and control subjects were assessed by using analysis of variance. Because the patients and control subjects did not show a significant difference in age and sex distribution, we did not enter these variables as covariates. The total intracranial volumes of the subjects were calculated and used as a covariate in the comparison analysis. The findings were considered significant at a voxel level of P Ͻ .05, corrected for multiple comparison familywise error (FWE), with an extended threshold looking for clusters with at least 20 contiguous voxels. The relationship between the clinical variables (duration of disease, immunoglobulin G [IgG] index, NDI scores) and cortical gray matter volume was investigated by regression analysis (P Ͻ .05, FWE-corrected). For localizing purposes, the MNI coordinates were converted to Talairach coordinates by using a dedicated script (mni2tal.m; available at: http://www.mrc-cbu.cam.ac.uk/ Imaging/Common/mnispace.shtml). An automated software was used to retrieve the brain labels for the Talairach coordinates (http://www.talairach.org/client.html).
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Results
The differences between the mean age and sex distribution of patients and control subjects were not significant (P Ͼ .05). Five of the patients were in stage 2 of the disease, and the remaining 12 patients had stage 1 SSPE. The mean clinical stage of the patients was 1.29. The mean duration of symptoms was 8.9 Ϯ 5.7 weeks (range, 3-24 weeks) ( Table 1) . Behavioral and personality changes were present in the clinical history of all patients (100%). The parents or teachers of 11 patients had noticed a recent decline in school performances of the patients. In addition to the behavioral changes, 5 patients also had involuntary movements in the head and limbs (myoclonic jerks). The neurologic evaluation of the patients revealed a mean NDI score of 15.8 Ϯ 5.3 (range, 10 -25). The findings of FLAIR and T2-weighted MR images of all patients and the control subjects were normal (Fig 1) .
Voxel-based comparison analysis revealed that the patients had significantly reduced cortical gray matter volume in the frontotemporal cortical regions compared with those in the control subjects ( Table 2 ). The regions with gray matter loss in patients included the anterior cingulate cortex (Talairach coordinates: x ϭ Ϫ7, y ϭ Ϫ15, z ϭ 41 [Brodmann area, (BA 24)]; x ϭ 6, y ϭ 0, z ϭ 35 [BA 24]) and the bilateral amygdala (x ϭ Ϫ32, y ϭ Ϫ1, z ϭ Ϫ12; x ϭ 30, y ϭ Ϫ3, z ϭ Ϫ10) (Fig 2) . The correlation analysis revealed that there was no significant association between the NDI scores and gray matter distribution of the patients. Moreover, there was no relationship between the IgG index or clinical stage and gray matter volumes of patients.
Comment
The uniformity of clinical progression in patients with SSPE suggests a common pattern of neuropathologic progress in the central nervous system. Previous autopsy reports revealed that inflammatory infiltrations in cortical gray matter are the prominent pathologic finding in the early periods of SSPE. 1, 15 In later stages of the disease, the neuropathologic findings spread into adjacent subcortical white matter. Early involvement of cortical gray matter would explain the nonspecific subtle behavioral symptoms that are frequently seen in the initial stages of SSPE. However, contrary to the early cortical involvement shown by the neuropathologic studies, conventional MR imaging examinations performed in patients with early disease usually reveal normal findings. Thus, cortical involvement in early SSPE could not be demonstrated in previous neuroimaging studies. The results of the current study revealed the reduced gray matter volume in the bilateral frontotemporal cortex, including the amygdala and cingulate cortex, of the patients with stage 1 and 2 SSPE.
Decreased frontotemporal cortical gray matter volume is consistent with the results of previous neuropathologic studies emphasizing the cortical involvement in the early periods of SSPE. The results of previous neuroimaging studies revealed that findings of cranial imaging performed in the initial stages of SSPE usually appear normal and that parenchymal lesions develop as the disease progresses. 1, 7 In the current study, we demonstrated the gray matter volume reduction in the patients with normal-appearing MR imaging findings in early stages of the disease. When we consider the results of the current and previous studies together, it suggests that a subtle loss of frontotemporal gray matter may precede the appearance of morphologic T2-weighted lesions in early SSPE. Kanemura et al 16 investigated the frontal lobe volume in a patient with early SSPE. They measured the whole parenchymal volume of frontal lobes including the white and gray matters volumes. They found a decreased frontal lobe volume compared with that in healthy control subjects, which seems to be a finding consistent with the results of the current study. In another article, Kanemura and Aihara 17 reported the decreased apparent diffusion coefficient in the normal-appearing frontal lobe of a patient with SSPE. They also found a correlation between the frontal diffusion changes and clinical parameters. They speculated about the possibility of an association between frontal neuropathologic changes and some of the clinical findings of SSPE.
Neurodegenerative diseases leading to progressive neuronal loss cause reduced cortical gray matter attenuation and volume in the related regions of brain. 18 SSPE is caused by persistent infection of neurons and oligodendrocytes by the measles virus. Neuronal degeneration, neuronal loss, demyelination, and gliosis are the main neuropathologic findings of SSPE. The decreased gray matter volume in the frontotemporal cortex of our patients might be the consequence of neuronal degeneration/loss in those regions of brain.
The cingulate gyrus and amygdala are components of the limbic cortex, which is involved in the processing of emotions. 19, 20 A complex neural network, including the prefrontal and anterior cingulate gyrus, hippocampus, insular cortex, and amygdala, is involved in the processing of various aspects of emotions. The pathologies affecting the anterior cingulate gyrus and amygdala cause emotional and behavioral symptoms. The amygdala is also involved in the regulation of emotions. Thus, any pathology affecting the amygdala may cause dysregulation of emotional processing leading to over-or underexpression of emotions. The initial symptoms of patients with SSPE include emotional instability, inappropriate emotions, inappropriate expression of emotions, and other behavioral changes. Cortical involvement in the cingulate gyrus and amygdala may explain the emotional and behavioral symptoms of early SSPE. Cognitive decline, which is usually recognized as a recent decrease in scholastic performance of the patient, is another common symptom of early SSPE. The anterior cingulate cortex together with the orbitofrontal cortex takes part in the processing of decision making. 21 The amygdala is also involved in reward-based learning and decision making. 22 Recent studies have shown that the amygdala is a critical structure in a neural system necessary for implementing advantageous decisions. Thus, the gray matter volume reduction in the anterior cingulate cortex and the amygdala may contribute to the appearance of cognitive decline during the initial stages of SSPE. However, we did not find a significant correlation between the NDI scores of patients and their cortical gray matter distribution. The NDI scoring is a gross evaluation of the motor and sensory functions as well as the mental states of patients with SSPE. The lack of a correlation between the NDI scores and gray matter volume might be because we studied only patients in the initial stages of the disease, and their NDI scores were distributed in a narrow range.
The correlation analysis in the current study did not reveal any association between the duration of symptoms and gray matter distribution in patients. This finding suggests that the gray matter loss in the frontotemporal regions might have developed at very early periods of the disease. The relatively narrow range of duration of symptoms among patients might be another explanation of this finding. Furthermore, we did not find any correlation between the IgG index and the gray matter distribution. This finding indicates that there is no association between the degree of neuroimmunologic reaction and gray matter loss in early SSPE.
Several quantitative imaging studies with a region-of-interest design such as quantitative diffusion MR imaging and proton MR spectroscopy 8, 9, 17 have been conducted to investigate the in vivo neuropathologic findings in patients with early SSPE. Because conventional imaging findings usually appear normal in early SSPE, quantitative imaging studies investigating patients with early SSPE require a prior hypothesis of localization. The frontotemporal weighting of cortical gray matter loss demonstrated by the current study may guide future studies investigating early imaging findings of SSPE.
A few limitations of the current study should be mentioned. First, because of the ethical issues, we did not perform a longitudinal study. A longitudinal study would give valuable information about the evolution of gray matter loss during the clinical progression of the disease. The second limitation may be that we could not measure the severity of the patients' emotional symptoms. Thus, we could not investigate the correla- tion between volumetric changes in gray matter and severity of behavioral symptoms. Although the comparison analysis revealed a gray matter reduction in the emotion-related regions of the brain, a correlation analysis would be helpful to investigate the association of the severity of emotional symptoms and gray matter distribution.
In conclusion, the results of the current study demonstrated the decreased gray matter volume in the frontotemporal cortex of patients in the early stages of SSPE. The gray matter volume reduction in the cingulate gyrus and amygdala, which are related to decision making and emotion processing, may contribute to the development of behavioral symptoms of early SSPE.
